Afatinib/gefitinib/osimertinibAcquired resistance: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1806卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79039-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：21 / 21

相关论文

共 50 条

[31] Afatinib/osimertinibDrug resistance: 5 case reports
Reactions Weekly, 2019, 1778 (1) : 18 - 18
[32] Gefitinib/osimertinibAcquired drug resistance and transformation to small cell lung cancer: case report
Reactions Weekly, 2020, 1804 (1) : 134 - 134
[33] Afatinib/crizotinib/gefitinibDevelopment of resistance: 2 case reports
Reactions Weekly, 2018, 1712 (1) : 34 - 34
[34] Afatinib/erlotinibRash and diarrhoea: 4 case reports
Reactions Weekly, 2017, 1662 (1) : 24 - 24
[35] Afatinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1708 (1) : 28 - 28
[36] OsimertinibAcquired resistance: case report
Reactions Weekly, 2021, 1836 (1) : 620 - 620
[37] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
Reactions Weekly, 2021, 1863 (1) : 165 - 165
[38] OsimertinibAcquired resistance: case report
Reactions Weekly, 2019, 1771 (1) : 235 - 235
[39] OsimertinibAcquired resistance: case report
Reactions Weekly, 2021, 1841 (1) : 202 - 202
[40] OsimertinibAcquired resistance: case report
Reactions Weekly, 2022, 1910 (1) : 381 - 381

← 1 2 3 4 5 →